Home > Income Statement > PIRAMAL PHARMA

PIRAMAL PHARMA
Revenue

    Back to Income Statement
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹9,151 Cr₹8,171 Cr₹7,082 Cr₹6,559 Cr₹6,315 Cr

What is the latest Revenue of PIRAMAL PHARMA ?

The latest Revenue ratio of PIRAMAL PHARMA is ₹9,151 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹9,151 Cr
Mar2024₹8,171 Cr
Mar2023₹7,082 Cr
Mar2022₹6,559 Cr
Mar2021₹6,315 Cr

How is Revenue of PIRAMAL PHARMA Trending?

Years Revenue % Change
Mar2025 ₹9,151 Cr
11.99
Mar2024 ₹8,171 Cr
15.39
Mar2023 ₹7,082 Cr
7.97
Mar2022 ₹6,559 Cr
3.87
Mar2021 ₹6,315 Cr -

Compare Revenue of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹22,709.4 Cr -4.7% 6.7% -16% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,909.0 Cr -2.5% 1% 7.5% Stock Analytics
DIVIS LABORATORIES ₹173,930.0 Cr -3.1% 0.3% -1.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹147,181.0 Cr -4.9% 2.8% 37.8% Stock Analytics
CIPLA ₹112,353.0 Cr -1.6% 5.6% -5.7% Stock Analytics
DR REDDYS LABORATORIES ₹107,608.0 Cr -3.2% -3.1% 4.8% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-4.7%

6.7%

-16%

SENSEX

-1.5%

-3.4%

-9.1%


You may also like the below Video Courses